ARTICLE | Clinical News
MG98: Phase II data
May 23, 2005 7:00 AM UTC
Data from the Phase II Step 1 trial of MG98 in combination with interferon alpha to treat renal cell cancer showed that 1 patient on the continuous infusion schedule experienced a confirmed partial re...